Eric Masy
Impact in
- Parasitology top 10%
- Toxoplasma gondii Research Studies
- Rheumatology top 10%
- Systemic Lupus Erythematosus Research
Papers in
-
- Systemic Lupus Erythematosus Research 4
- Oncology 3
- Viral-associated cancers and disorders 3
- Co-authors
- Jean‐Paul Dessaint (6 shared papers)Eric HACHULLA (4 shared papers)Bernard Devulder (3 shared papers)Marie‐France Cesbron‐Delauw (1 shared paper)Corinne Mercier (1 shared paper)Myriam Labalette (4 shared papers)Laurence Lecordier (1 shared paper)Eric Dehecq (1 shared paper)
In The Last Decade
Eric Masy
20 papers receiving 398 citations
Peers
Comparison fields: 5 of 33
- Parasitology 52
- Rheumatology 81
- Transplantation 6
- Oncology 39
- Genetics 35
Countries citing papers authored by Eric Masy
This map shows the geographic impact of Eric Masy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Masy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Masy more than expected).
Fields of papers citing papers by Eric Masy
This network shows the impact of papers produced by Eric Masy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Masy. The network helps show where Eric Masy may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Masy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 64 | |
| 2 | 2000 | 58 | |
| 3 | Elastase derived elastin peptides: putative autoimmune targets in giant cell arteritis. | 1997 | 40 |
| 4 | 2002 | 32 | |
| 5 | 2006 | 30 | |
| 6 | 2000 | 29 | |
| 7 | 2000 | 29 | |
| 8 | 1995 | 28 | |
| 9 | 1998 | 23 | |
| 10 | 1995 | 22 | |
| 11 | 1998 | 14 | |
| 12 | 2009 | 11 | |
| 13 | 1997 | 10 | |
| 14 | 2007 | 9 | |
| 15 | 1999 | 7 | |
| 16 | Individual susceptibility to cyclosporine: possible involvement of the CD28/CD80 (B7/BB1) pathway. | 1994 | 6 |
| 17 | Individual differences in the in vitro response to cyclosporin A (CsA): possible heterogeneity in the involvement of the CD28-B7/BB1 pathway. | 1995 | 3 |
| 18 | 1997 | 3 | |
| 19 | La protéine oncogène LMP1 du virus d'Epstein-Barr : voies de signalisation et phénotypes associés | 2002 | 1 |
| 20 | 2006 | 1 |
About Eric Masy
Eric Masy is a scholar working on Rheumatology, Oncology, Immunology, Parasitology and Genetics, having authored 20 papers that have together received 420 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (4 papers), Viral-associated cancers and disorders (3 papers), T-cell and B-cell Immunology (2 papers), Inflammatory Bowel Disease (2 papers), Vasculitis and related conditions (2 papers), Signaling Pathways in Disease (1 paper), Clinical Laboratory Practices and Quality Control (1 paper) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Parasitology (52 citations), Rheumatology (81 citations), Transplantation (6 citations), Oncology (39 citations) and Genetics (35 citations). Eric Masy has collaborated with scholars based in France and Tunisia. Frequent co-authors include Jean‐Paul Dessaint, Eric HACHULLA, Bernard Devulder, Marie‐France Cesbron‐Delauw, Corinne Mercier, Myriam Labalette, Laurence Lecordier, Eric Dehecq, J Arvieux and Viviane Queyrel. Their work appears in journals such as Journal of Virology, Transplantation, Digestive Diseases and Sciences, Transplant International and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.